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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S276Methods: Chondrocytes, MSC and a mixture of chondrocytes and MSC
(1:1) were embedded in a 3D-ﬁbringel and either kept in monoculture or
were cocultured with cartilage or subchondral bone explants (obtained
from arthroplastic surgery due to OA) for up to 28 days. Matrix production
and chondrogenic characteristics of cells were determined immunohis-
tologically (collagens I, II and III) and histologically (aggrecan) after 7,14, 21
and 28 days. Gene expression of SOX9, COL1A1, COL2A1, COL3A1 and
COL10A1 and of two miRNAs was analyzed after 7 and 28 days with
quantitative real-time PCR. Protein expression in the cell-ﬁbrin constructs
was assessed with ELISA (collagen I / II), western blot (Sox9, phospho-Sox9
and collagen III) and glycosaminoglycan (GAGs) production was analyzed
using a DMMB-assay. The culture supernatant was analyzed for collagen
fragments by a hydroxyproline assay and for PTHrP with an ELISA. We
separated the supernatants from MSC - monocultures versus cartilage
cocultures with SDS-PAGE and identiﬁed differentially secreted proteins
with MALDI-TOF.
Results: MSC underwent chondrogenic differentiation with respect to
collagen II expression in all culture conditions. In comparison to mono-
cultures, collagen I, II and III gene expression and protein production was
suppressed when MSC or chondrocytes were cocultured with cartilage or
subchondral bone explants. Mixed cultures of chondrocytes and MSC
showed a reduced collagen II production in all culture regimes. GAG
production and total collagen content in the supernatant was altered in
bone explant cocultures only. Phospho-Sox9 and PTHrP protein expression
were not signiﬁcantly affected by any culture condition. However,
preliminary data indicate a correlation between miRNA expression and
regulation of sox9 protein. MALDI-TOF analysis revealed several proteins/
factors present in coculture supernatants but not in the monocultured
controls (e.g. stromelysin-1, chondroadherin, ﬁbronectin and SPARC).
Conclusions: Chondrogenic differentiation of MSC is affected by the
microenvironmental conditions. Cartilage and subchondral bone explants
from OA-patients suppress collagen I, II and III gene expression and
production in MSC. This observation might be partly dependent on regu-
lation of sox9 protein biosynthesis by miRNA. Future studies with ovine
tissue will delineate if healthy cartilage/subchondral bone provokes
different responses in MSC compared to OA derived tissues.
Chondroadherin, ﬁbronectin, SPARC and stromelysin-1 among other, yet
unidentiﬁed proteins, were detected in coculture supernatants and might
be associated with the reduced collagen content in OA-cartilage/sub-
chondral bone cocultures of MSC. We will study a putative link between
these factors and regulation of collagen expression and degradation in
further analyses.
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T3 EFFECT THROUGH SCR2 ON CHONDROGENESIS IN VITRO
M.C. Arufe 1,2, A. De la Fuente 2, P. Fernández-Pernas 1, I. Fuentes-
Boquete 2, F. De Toro 2, F.J. Blanco 1,2. 1Dept. of Med.. Faculty of Hlth.Sci..
INIBIC-CHUAC, A Coruña, Spain; 2Osteoarticular and Aging Res. Lab..
INIBIC-CHUAC, A Coruña, Spain
Purpose: There are evidences about the thyroid hormone role into chon-
drogenesis but its molecular implication is not clear. The current study
treats to answer this question working about a new in vitro model of
chondrogenesis using mesenchymal stem cells (MSCs) from human
umbilical cord stroma tissues
Methods: The umbilical cord tissues were obtained from caesareans from
healthy women in the Maternity Facility at Complejo Hospitalario Uni-
versitario de A Coruña under the supervision of the hospital ethic
committee. MSCs were isolated from umbilical cord stroma tissue using an
enzymatic digestion and cultured the cells adhered to the plastic plate.
Chondrogenic process was performed using our model which consisted in
growing the cells during two days in mediumwith FCS 10% in DMEM. After
2 days the mediumwas replaced by a mediumwith KO serum and TGF-ß3
which induces the chondrogenesis. Different amounts of human T3 (1, 10
or 100 ng/mL) were adding to the medium to test their role into chon-
drogenesis process, also different experiments with T3 alone or together
with M151, a speciﬁc steroid covalent receptor type 2 (SCR2) inhibitor, in
the chondrogenic medium, were performance to check which was the T3
receptor which had a active role in the chondrogenesis. Spheroids made bythis method were collected after 7, 14 and 28 days in culture and storage at
-20oC for their posterior analysis. Immunohistochemistry analysis of
spheroids against COL2, COL1 and aggrecane stain was performed to check
chondrogenic differentiation stage and quantitative RT-PCR to check
expression of COL2, COL1 and SOX9 genes also was made. Furthermore,
proteins involved into Wnt (Beta-catenin and GSK3-B) and Notch (Notch2
and Jagged) pathways were analyzed by western.
Results: Immunohistochemistry analysis of the tissues from the spheroids
demonstrated that 100 ng/mL of T3 improved signiﬁcantly (P<0.05) the
COL2andaggrecane staining after 14 days into chondrogenicmediumversus
chondrogenic medium without T3. This improving was totally withdrawal
when the SCR2 inhibitor, M151, was added to themedium at 2.5 ng/mL dose.
Quantitative RT-PCR analysis conﬁrm the immunohistochemistry results,
improving signiﬁcantly (P<0.05) the COL2 and aggrecane gene expression
after 14 days into chondrogenic mediumwhen 100 ng/mL of T3was present
and revealed that expression of COL1 was signiﬁcantly increased (P<0.05)
when M151 (2.5 ng/mL) was added to this medium. Western analysis indi-
cated that Beta-cateninwas increased in the spheroidswhenT3 (100 ng/mL)
was in the medium after 14 days (2 fold) with respect to medium alone and
was decreased until basal levels found in spheroids growth into medium
without T3, whenM151 (2.5 ng/mL)was present in themedium.Notch2 and
Jagged was decreased (2 fold) during the chondrogenesis when T3 was
present in themediumwith respect tomediumalone and the opposite effect
was found when M151 was present in the medium.
Conclusions: T3 is improving the chondrogenic differentiation of
mesenchymal stem cells from umbilical cord tissue. That effect was made
through SCR2 as well as T3 is associated the expression of B-catenin and
Notch2 in our chondrogenic model.
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INTRA-ARTICULAR INJECTION OF ADIPOSE-DERIVED STEM CELLS
PREVENTS CARTILAGE DESTRUCTION, NEW BONE FORMATION IN THE
LIGAMENTS AND LOWERS SYNOVIAL ACTIVATION
M.C. ter Huurne 1, P.L. van Lent 1, A.B. Blom 1, R. Blattes 2, L. Casteilla 2,
C. Jorgensen 3, W.B. van den Berg 1. 1Radboud Univ. Nijmegen Med. Ctr.,
Nijmegen, Netherlands; 2 STROMALab UPS/CNRS UMR5273, EFS, INSERM
U1031, Toulouse, France; 3 Inserm, Montpellier, France
Purpose: Synovial activation is evident in a substantial subpopulation of
patients with early osteoarthritis (OA) and has been associated with
pathophysiology and clinical symptoms of OA. Previous studies have
shown that activated synovial macrophages are involved in mediating
cartilage destruction as well as the formation of osteophytes during
experimental OA. Recently it has been shown that Adipose-derived
Stroma/Stem Cells (ASCs) express immunosuppressive characteristics. The
aim of our study was to explore the effect of an intra-articular injection of
ASCs on joint pathology during experimental OA.
Methods: ASCs were isolated from inguinal fat surrounding the popliteal
lymph nodes and cultured for two weeks according to standard proce-
dures. ASC were characterized with FACS analysis on a set of speciﬁc cell
surface markers. Experimental OAwas induced by injection of collagenase
into murine knee joints, which causes instability and cartilage destruction.
Collagenase-induced OA is characterized by thickening and activation of
the synovial lining layer. ASCs were injected into knee joints at various
time-points after induction of OA. OA phenotypes were measured within 8
weeks after induction. Total knee joints were isolated and processed for
histology. Synovial activation was measured using an arbitrary scale (0 to
3) and cartilage destruction was measured in 4 different layers of the knee
joint (medial and lateral tibia and femur) according to the scoring method
of Pritzker et al. 2006. Moreover, newly formed bone in the ligaments was
quantiﬁed using image analyses.
Results: After culture FACS analysis showed that the adherent fraction
expressed characteristic markers for stem cells (positive staining for Sca-1,
CD-44 and CD-105 and negative staining for CD-11b and cKIT). A single
dose of ASCs (20x103 in mouse serum) was injected into the knee joint of
mice, 7 days after induction of osteoarthritis. Synovial activation was
inhibited at day 14 (9%) and day 42 (31%) (P< 0.05) after treatment when
compared to serum injected knee joints. Destruction of cartilage was also
inhibited at day 14 and signiﬁcantly at day 42 (35%). Inhibition of cartilage
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Interestingly, ASC-treatment had a protective effect on new cartilage and
bone formation in the ligaments. At day 42, the surface percentage of the
cruciate ligament which stained positive for proteoglycan deposition was
decreased by nearly 43% in the ASC treated joints when compared to
controls. In line with that, osteophyte formation in the medial collateral
ligament was signiﬁcantly reduced by 91% in ASC-treated animals
compared to control. In contrast to early treatment, injection of the same
dose of ASCs, 14 days after induction of OA only showed a small inhibiting
effect on osteophyt formation and synovial activation when measured at
day 42. Although cartilage destruction diminished with 28%, these values
did not reach signiﬁcance at that time-point.
Conclusions: Our study indicates that a single injection of ASCs into the
knee joints of mice with collagenase-induced osteoarthritis prevents
cartilage damage and the formation of bone structures within the liga-
ments, probably by inhibiting activation of the synovial macrophages.
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CHONDROGENIC AND IMMUNOPHENOTYPIC PROPERTIES OF
MESENCHYMAL STEM CELLS FROM OSTEOARTHRITIS PATIENTS
S. Hagmann, B. Moradi, S. Frank, A.-M. Bäsig, T. Dreher, W. Richter,
T. Gotterbarm. Dept. of Orthopedics and Traumatology, Heidelberg, Germany
Purpose:Mesenchymal stem cells (MSCs) are a promising target for future
cell-based therapies in osteoarthritis. In this context, cartilage tissue
engineering is a major ﬁeld of research, with effective cartilage repair
being the ultimate objective. There is a controversy whether osteoarthritis
and age affect the regenerative potential of MSCs. Also, in the last decade, it
has become clear that MSCs are heterogeneous populations not only
regarding their regenerative potential, but also regarding their surface
markers. The aim of this study was to analyse the inﬂuence of osteoar-
thritis and age on growth parameters, immunophenotype and chondro-
genic differentiation potential of human bone marrow derived MSCs.
Methods:MSCs were isolated from bone marrow of osteoarthritis patients
(n¼5, OA) and patients without clinical and radiological signs of osteoar-
thritis (n¼5, non-OA) and expanded in different cell culture media. Flow
cytometry analysis was performed for CD10, CD13, CD14, CD34, CD44,
CD45, CD49, CD73, CD90, CD105, CD117, CD133, CD 140b, CD 166, CD271,
CD340, Stro-1 and HLA-ABC. Chondrogenic differentiation was induced
with chondrogenic medium in pellet culture. Chondrogenic differentiation
potential was evaluated by a DMMB-assay and by semiquantitative anal-
ysis of GAG percentage (SafraninO/FastGreen staining). Statistical analysis
as performed with analyses of variance (ANOVA).
Results: Both in the OA and the non-OA group, MSCs were negative for
CD14, CD34 and CD45 and positive for CD13, CD44, CD73, CD90, CD105 and
CD166. CD49, CD105, CD140b, CD146, CD340 and Stro-1 showed differ-
ences depending from the media applied, but no signiﬁcant differences
were observed between the OA and non-OA group. The expression of the
MSC surface markers CD10, CD49 and CD146 showed high donor depen-
dence while for these markers there was no signiﬁcant difference between
the OA and the non-OA group. Cell proliferation differed substantiallyMonths n Suture
Load to failure (N) 1 4 1.31 [1.19-1.69]
2 4 1.22 [0.76-1.60]
3 3 1.14 [0.28-1.29]
Total n 11
Stiffness (N/mm) 1 4 1.20 [0.99-1.42]
2 4 0.86 [0.49-0.91]c
3 3 0.70 [0.37-0.90]a
Total n 11
Deformation (mm) 1 4 1.13 [0.77-1.40]
2 4 1.53 [1.13-1.75]
3 3 1.15 [0.68-1.68]
Total n 11
a Statistically signiﬁcant from same group repair.
b Statistically signiﬁcant from Suture vs MSC-Membrane
c Statistically signiﬁcant from Membrane vs MSC-Membranebetween different culture media while the growth index parameters were
similar in the OA and non-OA group. There was no difference in MSC
chondrogenic potential between OA and non OA patients while the culture
media had an important inﬂuence on chondrogenic differentiation.
Conclusions: Our ﬁndings add to the reports that negate the regenerative
inferiority of MSCs from OA affected patients. Our experiments rather
suggest that MSCs extracted from OA patients are an adequate source for
cartilage tissue engineering, which is supported by the ﬁnding that MSC
surface markers do not seem to be inﬂuenced by age or presence of OA.
Our data also reﬂects that MSCs are heterogeneous regarding some of their
surface markers and that culture conditions seem to have an important
inﬂuence on both immunophenotype and chondrogenic potential.
In the long-term, understanding the potential of MSC heterogeneity and of
culture conditions will hopefully lead to more efﬁcient cartilage tissue
engineering.
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LONG-TERM EFFICACY OF MESENCHYMAL STEM CELLS IMPLANTATION
IN COMBINATION WITH TYPE I COLLAGEN MEMBRANE: A RAT
EXPERIMENTAL MODEL OF ROTATOR CUFF TEARS.
P. Tornero-Esteban, C. Rodriguez-Bobada, J. Hoyas, E. Villafuertes,
F. Marco, B. Fernandez-Gutierrez. Hosp. Clinico San Carlos, Madrid, Spain
Purpose: The Supraspinatus tendon (SE) is an essential structure for the
proper function of the rotator cuff frequently affected in rotator cuff tears.
Common surgical procedures to repair SE lesions are usually adequate in
the short term, but they are often unsatisfactory in the long term pre-
senting a high rate of re-rupture. In this context, there is a need for new
techniques allowing a more efﬁcient repair. Regenerative medicine using
mesenchymal stem cells (MSCs) offers a promising alternative. This study
explore in a rat model the possible beneﬁts of a treatment based on MSC-
collagen membrane graft compared to conventional treatment (suture) or
collagen membrane graft.
Methods: A chronic rotator cuff tear injury model was developed by
unilaterally detaching the SE tendon of adult Sprague-Dawley rats. One
month post-injury, the tendon was repaired by: a) Classical surgery, using
single suture. b) suture + type I collagen membranes without cells;
Membrane or c) suture + type I collagen membranes + 1x106 allogeneic
MSCs; (n¼12; MSC-Membrane). Lesion was evaluated at 1 month, 2
months and three months post-injury by biomechanical criteria including
“load-to-failure” measured (Newtons), Stifness (N/mm) and deformation
(mm). The opposing and not injured shoulder was used as positive control
after normalization. Non-parametric Mann-Whitney U test was used for
statistical analysis, p < 0.05 was considered signiﬁcant.
Results: Biomechanical properties (median [25%-75% percentil]) of tendon
repair
Conclusions: We observed that implanting MSC-Membrane into surgi-
cally created tendon defects improved the strength and stiffness of the
repaired tendon at three months, indicating that the reparation process
ameliorated after long-term. This likely indicates that long-term efﬁcacy
is inﬂuenced by underlying mechanism improving the natural tendon
repair.n Membrane n MSC-Membrane
6 0.73 [0.35-1.23] 6 1.04 [0.77-1.22]b
4 0.99 [0.63-1.59] 5 1.11 [0.74-1.39]
5 0.94 [0.84-1.27] 4 1.70 [1.27-1.79]a,b,c
15 15
6 0.62 [0.44-0.88] 6 0.63 [0.46-0.90]
4 0.87 [0.53-2.15] 5 0.66 [0.47-1.05]
5 0.91 [0.60-2.03] 4 1.16 [1.04-1.32] a,b
15 15
6 1.12 [0.84-1.66] 6 1.21 [0.83-2.02]
4 1.01 [0.82-1.65] 5 0.98 [0.84-1.92]
5 1.32 [0.54-2.30] 4 1.30 [0.84-1.42]
15 15
